patients should discuss risks and benefits with their healthcare provider
additional contraceptive methods are recommended for 4 weeks after initiation and after each dose increase [3] [6] Tirzepatide is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis Patients should inform all healthcare providers, including surgical teams, about tirzepatide use Treatment is likely long-term, as weight regain typically occurs upon discontinuation Patients should be monitored for adequate nutrition and hydration, particularly if appetite suppression is pronounced
Considerations With GLP-1 Medications At Ageless Wellness, your safety comes first
Status Investigational
Over time, skin is exposed to oxidative stress from UV rays, pollution, and even the natural aging process, all of which contribute to the development of age spots, or sun spots, and an uneven complexion
27 (9): 5008 DOI: 10.1111/dom.16548 Cite This Page : ScienceDaily